Abemaciclib

Red

Brand Name(s):Verzenios

Indication:Cancer -breast

Rationale:1,2,3

Considered:Oct-18

Review Date:Jul-26

Comments:
MHRA warns cases of interstitial lung disease and pneumonitis have been reported in patients receiving this CDK4/6 inhibitor. Patients should be advised of the need to seek advice right away if they develop new or worsening respiratory symptoms.

June ’21